Neoadjuvant Chemotherapy With the Angiogenesis Inhibitor Bevacizumab for Locally Advanced Cervical Cancer.

MLA

Sunhwa Baek, et al. “Neoadjuvant Chemotherapy With the Angiogenesis Inhibitor Bevacizumab for Locally Advanced Cervical Cancer.” In Vivo, vol. 38, no. 6, Nov. 2024, pp. 3068–77. EBSCOhost, https://doi.org/10.21873/invivo.13791.

APA

Sunhwa Baek, Ka-Won Noh, Yue Zhao, Schoemig-Markiefka, B., Ratiu, D., Domroese, C., Mallmann, M., Mallmann, P., & Pilch, H. (2024). Neoadjuvant Chemotherapy With the Angiogenesis Inhibitor Bevacizumab for Locally Advanced Cervical Cancer. In Vivo, 38(6), 3068–3077. https://doi.org/10.21873/invivo.13791

Chicago

Sunhwa Baek, Ka-Won Noh, Yue Zhao, Birgid Schoemig-Markiefka, Dominik Ratiu, Christian Domroese, Michael Mallmann, Peter Mallmann, and Henryk Pilch. 2024. “Neoadjuvant Chemotherapy With the Angiogenesis Inhibitor Bevacizumab for Locally Advanced Cervical Cancer.” In Vivo 38 (6): 3068–77. doi:10.21873/invivo.13791.